Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Meggitt surges on merger mumbles, Carney chat hits housebuilders

Tue, 14th Jul 2015 14:29

(ShareCast News) - London markets edged lower on Tuesday, as losses from housebuilders, engineers and financials eclipsed gains made by industrial metals.As of 14:00 BST, the FTSE 100 was trading 0.2% lower at 6,727.Shares in defence and aerospace engineer Meggitt rose following a report in the Financial Times that a merger with Cobham might be on the cards. Atif Latif, director of trading at Guardian Stockbrokers, said he sees the rationale of a tie-up between the two as a defence play.AstraZeneca gained as its Iressa drug, which is used in the treatment of metastatic non-small cell lung cancer (NSCLC), was approved by the US Food and Drug Administration. Iressa is already approved in 91 countries for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor mutation-positive NSCLC, which is the most common type of lung cancer.Sky surged as analysts at Deutsche Bank upgraded their rating on the stock from 'hold' to 'buy' and raised estimates for 2017 by 20% more than the wider consensus. In a note to clients, Deutsche Bank said the European satellite TV giant was the best positioned in Europe to capitalise on growth areas related to online video.Meanwhile ITV was under the cosh in early trading after Deutsche Bank downgraded the stock to 'sell' from 'hold'. "We find the upside case of retransmission fees, Liberty takeout and cash returns/dividends unconvincing," said the bank.This seemed to outweigh a note from Morgan Stanley on the media sector that picked out ITV as one of its favoured stocks, while also downgrading Pearson to 'equal weight' from 'overweight'. Pearson's shares fell around 1.8% by mid afternoon.Shares in housebuilders such as Taylor Wimpey, Barratt Developments and Persimmon were all knocked lower as Mark Carney told the Treasury Select Committee that the bank rate may be headed higher a little bit sooner than markets anticipated.RisersSky (SKY) 1,115.00p +3.43%Meggitt (MGGT) 480.80p +2.19%Morrison (Wm) Supermarkets (MRW) 180.10p +1.18%Sainsbury (J) (SBRY) 265.40p +0.87%Reed Elsevier (REL) 1,094.00p +0.83%Glencore (GLEN) 252.40p +0.80%Unilever (ULVR) 2,903.00p +0.76%Direct Line Insurance Group (DLG) 348.30p +0.66%Tesco (TSCO) 213.85p +0.64%British American Tobacco (BATS) 3,639.00p +0.61%FallersTaylor Wimpey (TW.) 185.40p -3.39%Persimmon (PSN) 1,958.00p -2.78%Barratt Developments (BDEV) 624.00p -2.73%GKN (GKN) 317.10p -2.28%TUI AG Reg Shs (DI) (TUI) 1,066.00p -1.93%Weir Group (WEIR) 1,595.00p -1.73%Aberdeen Asset Management (ADN) 402.50p -1.61%Johnson Matthey (JMAT) 3,005.00p -1.48%Hammerson (HMSO) 652.50p -1.44%Marks & Spencer Group (MKS) 540.00p -1.37%
More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.